{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:40:37Z","timestamp":1790138437094,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133242","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T14:26:06Z","timestamp":1437747966000},"page":"e0133242","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Na\u00efve Patients with HIV Infection: A Retrospective Cohort Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Jianjun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangkai","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-151-4-200908180-00006","article-title":"Five-year outcomes of the China National Free Antiretroviral Treatment Program","volume":"151","author":"F Zhang","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(12)61898-4","article-title":"Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003\u201311): a national observational cohort study","volume":"382","author":"Z Jia","year":"2013","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/526524","article-title":"Long-Term Effectiveness of Highly Active Antiretroviral Therapy on the Survival of Children and Adolescents with HIV Infection: A 10-Year Follow-Up Study","volume":"46","author":"K Patel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/QAI.0b013e31824c3d9f","article-title":"Association Between Missed Early Visits and Mortality Among Patients of China National Free Antiretroviral Treatment Cohort","volume":"60","author":"Y Zhang","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(11)70097-4","article-title":"Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study","volume":"11","author":"F Zhang","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1097\/QAD.0000000000000232","article-title":"Early initiation of antiretroviral therapy in HIV-infected adults and adolescents","volume":"28","author":"A Anglemyer","year":"2014","journal-title":"AIDS"},{"key":"ref7","article-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach","year":"2013"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1471-2334-13-301","article-title":"Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study","volume":"13","author":"Y Cao","year":"2013","journal-title":"Bmc Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1258\/ijsa.2010.010114","article-title":"Minimum effective plasma concentration of efavirenz in treatment-naive Chinese HIV-infected patients","volume":"21","author":"J Sun","year":"2010","journal-title":"Int J STD AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e94854","DOI":"10.1371\/journal.pone.0094854","article-title":"Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine&apos;s Epitaph?","volume":"9","author":"FS Sarfo","year":"2014","journal-title":"PLoS ONE"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1089\/aid.2008.0083","article-title":"Short-Term Discontinuation of HAART Regimens More Common in Vulnerable Patient Populations","volume":"24","author":"LS Robison","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1468-1293.2009.00750.x","article-title":"Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients","volume":"11","author":"P Cicconi","year":"2010","journal-title":"HIV Med"},{"key":"ref13","first-page":"RRN1203","article-title":"HLA-B*5701 testing to predict abacavir hypersensitivity","volume":"2","author":"JD Ma","year":"2010","journal-title":"PLoS Curr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1468-1293.2008.00561.x","article-title":"The prevalence of transmitted antiretroviral drug resistance in treatment-na\u00efve patients and factors influencing first-line treatment regimen selection","volume":"9","author":"HY Huang","year":"2008","journal-title":"HIV Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1310\/hct1501-27","article-title":"Durability of the First Antiretroviral Treatment Regimen and Reasons for Change in Patients With HIV Infection","volume":"15","author":"J De La Torre-Lima","year":"2014","journal-title":"HIV Clin Trials"},{"key":"ref16","first-page":"27803","article-title":"Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002\u20132009","author":"S Abgrall","year":"2013","journal-title":"AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e96307","DOI":"10.1371\/journal.pone.0096307","article-title":"Determinants of Highly Active Antiretroviral Therapy Duration in HIV-1-Infected Children and Adolescents in Madrid, Spain, from 1996 to 2012","volume":"9","author":"C Palladino","year":"2014","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-200101260-00007","article-title":"Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre","volume":"15","author":"A Mocroft","year":"2001","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e108615","DOI":"10.1371\/journal.pone.0108615","article-title":"Retention and Risk Factors for Attrition in a Large Public Health ART Program in Myanmar: A Retrospective Cohort Analysis","volume":"9","author":"A Thida","year":"2014","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.12659\/MSM.889283","article-title":"Toxicity-related antiretroviral drug treatment modifications in individuals starting therapy: A cohort analysis of time patterns, sex, and other risk factors","volume":"19","author":"Mihanovi\u0107 M Perovi\u0107","year":"2013","journal-title":"Med Sci Monit"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/1471-2458-14-831","article-title":"Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study","volume":"14","author":"H Zheng","year":"2014","journal-title":"BMC Public Health"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5582\/bst.2014.01015","article-title":"Why are some HIV\/AIDS patients reluctant to receive antiviral therapy as soon as possible in China?","volume":"8","author":"Y Sun","year":"2014","journal-title":"Biosci Trends"},{"key":"ref23","article-title":"Perceived stigma, medical social support and quality of life among people living with HIV\/AIDS in Hunan, China","author":"X Wu","year":"2014","journal-title":"Appl Nurs Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e75915","DOI":"10.1371\/journal.pone.0075915","article-title":"Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China","volume":"8","author":"J Xiao","year":"2013","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2334-4-52","article-title":"Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India","volume":"4","author":"SK Sharma","year":"2004","journal-title":"Bmc Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/QAD.0b013e32828cc8b7","article-title":"Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia","volume":"21","author":"L Ferradini","year":"2007","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1468-1293.2008.00616.x","article-title":"Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study","volume":"9","author":"H Ait-Mohand","year":"2008","journal-title":"HIV Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"JE Gallant","year":"2004","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1086\/521112","article-title":"Antiretroviral Therapy\u2013Associated Toxicities in the Resource\u2010Poor World: The Challenge of a Limited Formulary","volume":"196","author":"RA Murphy","year":"2007","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1590\/S1413-86702009000200012","article-title":"Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients","volume":"13","author":"H Domingos","year":"2009","journal-title":"Braz J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/COH.0000000000000004","article-title":"Beyond first-line HIV treatment regimens","volume":"8","author":"N Kumarasamy","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e63596","DOI":"10.1371\/journal.pone.0063596","article-title":"Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir","volume":"8","author":"C Njuguna","year":"2013","journal-title":"PLoS ONE"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"18794","DOI":"10.7448\/IAS.16.1.18794","article-title":"Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa","volume":"16","author":"AT Brennan","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/588141","article-title":"Durability and Outcome of Initial Antiretroviral Treatments Received during 2000\u20132005 by Patients in the Swiss HIV Cohort Study","volume":"197","author":"TTN Vo","year":"2008","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archinternmed.2009.432","article-title":"Treatment Modification in Human Immunodeficiency Virus\u2013Infected Individuals Starting Combination Antiretroviral Therapy Between 2005 and 2008","volume":"170","author":"L Elzi","year":"2010","journal-title":"Arch Intern Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:51:46Z","timestamp":1540014706000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133242"}},"subtitle":[],"editor":[{"given":"Shibo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133242","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}